Cite
HARVARD Citation
Defachelles, A. et al. (2021). Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial. Journal of clinical oncology. 39 (27), pp. 2979-2990. [Online].